Moguisteine

Drug Profile

Moguisteine

Alternative Names: BBR 2173

Latest Information Update: 07 Feb 2001

Price : $50

At a glance

  • Originator Roche
  • Class Antitussives; Small molecules; Thiazolidines
  • Mechanism of Action Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cough

Most Recent Events

  • 07 Feb 2001 Discontinued-preregistration for Cough in Italy (PO)
  • 13 Oct 1998 Recordati has an agreement with Boehringer Mannheim to supply industrial quantities of moguisteine
  • 10 Jun 1997 Preregistration for Cough in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top